Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans
Background The phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride‐rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride‐rich very‐low‐density lipoprotein (VLDL), (V...
Saved in:
Published in | Journal of internal medicine Vol. 291; no. 2; pp. 218 - 223 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.02.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 0954-6820 1365-2796 1365-2796 |
DOI | 10.1111/joim.13375 |
Cover
Loading…
Abstract | Background
The phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride‐rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride‐rich very‐low‐density lipoprotein (VLDL), (VLDL1), and smaller VLDL2 in homozygotes for the PNPLA3‐148M variant.
Methods and results
The kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3‐148M and nine subjects homozygous for PNPLA3‐148I (controls). Liver fat was >3‐fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2‐apoB100 and ‐triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2, were not significantly different.
Conclusions
Despite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects. |
---|---|
AbstractList | The PNPLA3-148M variant is associated with liver steatosis but its influence on metabolism of triglyceride-rich lipoproteins remains unclear. Here we investigated the kinetics of large, triglyceride-rich VLDL1 and smaller VLDL2 in homozygotes for the PNPLA3-148M variant.The kinetics of apoB100 and triglyceride in VLDL subfractions was analysed in nine subjects homozygous for PNPLA3-148M and nine subjects homozygous for PNPLA3-148I (controls). Liver fat was >3-fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2 -apoB100 and -triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2 , were not significantly different.Despite the higher liver fat content in PNPLA3-148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects. This article is protected by copyright. All rights reserved. The phospholipase domain-containing 3 gene (PNPLA3)-148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride-rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride-rich very-low-density lipoprotein (VLDL), (VLDL ), and smaller VLDL in homozygotes for the PNPLA3-148M variant. The kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3-148M and nine subjects homozygous for PNPLA3-148I (controls). Liver fat was >3-fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL did not differ significantly between the two groups. Likewise, production rates for VLDL -apoB100 and -triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL and VLDL , were not significantly different. Despite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects. Background The phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride‐rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride‐rich very‐low‐density lipoprotein (VLDL), (VLDL1), and smaller VLDL2 in homozygotes for the PNPLA3‐148M variant. Methods and results The kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3‐148M and nine subjects homozygous for PNPLA3‐148I (controls). Liver fat was >3‐fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2‐apoB100 and ‐triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2, were not significantly different. Conclusions Despite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects. BackgroundThe phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride‐rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride‐rich very‐low‐density lipoprotein (VLDL), (VLDL1), and smaller VLDL2 in homozygotes for the PNPLA3‐148M variant.Methods and resultsThe kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3‐148M and nine subjects homozygous for PNPLA3‐148I (controls). Liver fat was >3‐fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2‐apoB100 and ‐triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2, were not significantly different.ConclusionsDespite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects. The phospholipase domain-containing 3 gene (PNPLA3)-148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride-rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride-rich very-low-density lipoprotein (VLDL), (VLDL1 ), and smaller VLDL2 in homozygotes for the PNPLA3-148M variant.BACKGROUNDThe phospholipase domain-containing 3 gene (PNPLA3)-148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride-rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride-rich very-low-density lipoprotein (VLDL), (VLDL1 ), and smaller VLDL2 in homozygotes for the PNPLA3-148M variant.The kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3-148M and nine subjects homozygous for PNPLA3-148I (controls). Liver fat was >3-fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2 -apoB100 and -triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2 , were not significantly different.METHODS AND RESULTSThe kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3-148M and nine subjects homozygous for PNPLA3-148I (controls). Liver fat was >3-fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2 -apoB100 and -triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2 , were not significantly different.Despite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects.CONCLUSIONSDespite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects. |
Author | Ainola, Mari Borén, Jan Adiels, Martin Ripatti, Pietari Rämö, Joel Ripatti, Samuli Palotie, Aarno Söderlund, Sanni Henricsson, Marcus Hakkarainen, Antti Matikainen, Niina Packard, Chris J. Mancina, Rosellina M. Romeo, Stefano Taskinen, Marja‐Riitta Björnson, Elias |
Author_xml | – sequence: 1 givenname: Jan orcidid: 0000-0003-0786-8091 surname: Borén fullname: Borén, Jan email: jan.boren@wlab.gu.se organization: Sahlgrenska University Hospital – sequence: 2 givenname: Martin surname: Adiels fullname: Adiels, Martin organization: University of Gothenburg – sequence: 3 givenname: Elias surname: Björnson fullname: Björnson, Elias organization: University of Gothenburg – sequence: 4 givenname: Niina surname: Matikainen fullname: Matikainen, Niina organization: Helsinki University Hospital – sequence: 5 givenname: Sanni surname: Söderlund fullname: Söderlund, Sanni organization: Helsinki University Hospital – sequence: 6 givenname: Joel surname: Rämö fullname: Rämö, Joel organization: University of Helsinki – sequence: 7 givenname: Marcus surname: Henricsson fullname: Henricsson, Marcus organization: University of Gothenburg – sequence: 8 givenname: Pietari surname: Ripatti fullname: Ripatti, Pietari organization: University of Helsinki – sequence: 9 givenname: Samuli surname: Ripatti fullname: Ripatti, Samuli organization: University of Helsinki – sequence: 10 givenname: Aarno surname: Palotie fullname: Palotie, Aarno organization: Broad Institute of the Massachusetts Institute of Technology and Harvard University – sequence: 11 givenname: Rosellina M. surname: Mancina fullname: Mancina, Rosellina M. organization: University of Gothenburg – sequence: 12 givenname: Mari surname: Ainola fullname: Ainola, Mari organization: University of Helsinki – sequence: 13 givenname: Antti surname: Hakkarainen fullname: Hakkarainen, Antti organization: University of Helsinki – sequence: 14 givenname: Stefano surname: Romeo fullname: Romeo, Stefano organization: Sahlgrenska University Hospital – sequence: 15 givenname: Chris J. surname: Packard fullname: Packard, Chris J. organization: University of Glasgow – sequence: 16 givenname: Marja‐Riitta surname: Taskinen fullname: Taskinen, Marja‐Riitta organization: University of Helsinki |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34411351$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/306550$$DView record from Swedish Publication Index |
BookMark | eNp9kc1u1DAUhS1URKeFDQ-ALLFBSCn-T7KsqgKDprQLWFt2ct16lNghThjNjkfgGXkSPKRlUSG8sHXt71xdn3OCjkIMgNBLSs5oXu-20fdnlPNSPkErypUsWFmrI7QitRSFqhg5RicpbQmhnCjyDB1zISjlkq6QvXQOminh6PDN55vNOcdrKqorHAO-g8FMvsGdH3yLTWjxdxj3v3787OIu7y2E5Kf94TkOY5zAB9zDZGzsfOpxru7m3oT0HD11pkvw4v48RV_fX365-Fhsrj-sL843RSM4lYVtSlryltVlaSpZGqlaQSoKVnLpmkrwOlNQEylbcNaBcYwoZqvWuZbbUvJTVCx90w6G2eph9L0Z9zoar2_nQeer21kn0NkEKUnm3yx8Hv7bDGnSvU8NdJ0JEOekmVRcMMVrldHXj9BtnMeQf6OZYqQWnKs6U6_uqdn20P4d4MHtDJAFaMaY0ghON37KFscwjcZ3mhJ9CFQfAtV_As2St48kD13_CdMF3vkO9v8h9afr9dWi-Q17bLF8 |
CitedBy_id | crossref_primary_10_1002_ueg2_12556 crossref_primary_10_1038_s41569_022_00676_y crossref_primary_10_1177_20420188221145549 crossref_primary_10_1016_j_jhepr_2024_101185 crossref_primary_10_3390_biomedicines11071961 crossref_primary_10_1016_j_atherosclerosis_2023_117410 crossref_primary_10_1016_j_tem_2024_07_015 crossref_primary_10_1038_s41467_024_49224_x crossref_primary_10_1111_liv_16117 crossref_primary_10_1146_annurev_nutr_062222_020716 |
Cites_doi | 10.1038/s41575-019-0212-0 10.1161/ATVBAHA.107.160192 10.1074/jbc.RA118.002333 10.1210/jc.2005-1709 10.1002/oby.20366 10.1016/j.jhep.2020.03.039 10.1161/ATVBAHA.115.305614 10.1172/jci.insight.144079 10.1002/hep.30583 10.1152/ajpgi.00049.2020 10.1007/s00125-019-05024-3 10.1002/oby.20781 10.1007/s00125-005-0125-z 10.1016/j.jhep.2012.07.030 10.1093/eurheartj/ehx662 10.1111/joim.13017 10.1161/CIRCRESAHA.119.316337 10.1016/S0026-0495(96)90152-3 10.1194/jlr.M400108-JLR200 |
ContentType | Journal Article |
Copyright | 2021 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2021 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. – notice: 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. – notice: 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL C1K K9. 7X8 ADTPV AOWAS F1U |
DOI | 10.1111/joim.13375 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic SwePub SwePub Articles SWEPUB Göteborgs universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2796 |
EndPage | 223 |
ExternalDocumentID | oai_gup_ub_gu_se_306550 34411351 10_1111_joim_13375 JOIM13375 |
Genre | shortCommunication Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29K 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SJN SUPJJ TEORI TR2 UB1 V8K V9Y VH1 VVN W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZCG ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM PKN 7QL AAMMB AEFGJ AGXDD AIDQK AIDYY C1K K9. 7X8 ADTPV AOWAS F1U |
ID | FETCH-LOGICAL-c4315-bc7173d2977a857a56d4081eb535fc8439315e9055defbfeaf2062b8dffd3b753 |
IEDL.DBID | 24P |
ISSN | 0954-6820 1365-2796 |
IngestDate | Thu Aug 21 06:30:00 EDT 2025 Thu Jul 10 22:05:22 EDT 2025 Fri Jul 25 21:18:02 EDT 2025 Wed Feb 19 02:26:44 EST 2025 Tue Jul 01 00:45:40 EDT 2025 Thu Apr 24 22:53:08 EDT 2025 Wed Jan 22 16:26:12 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | fatty liver triglycerides lipoproteins lipid metabolism |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4315-bc7173d2977a857a56d4081eb535fc8439315e9055defbfeaf2062b8dffd3b753 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-0786-8091 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.13375 |
PMID | 34411351 |
PQID | 2620943369 |
PQPubID | 30713 |
PageCount | 6 |
ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_306550 proquest_miscellaneous_2563426396 proquest_journals_2620943369 pubmed_primary_34411351 crossref_citationtrail_10_1111_joim_13375 crossref_primary_10_1111_joim_13375 wiley_primary_10_1111_joim_13375_JOIM13375 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2022 |
PublicationDateYYYYMMDD | 2022-02-01 |
PublicationDate_xml | – month: 02 year: 2022 text: February 2022 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Journal of internal medicine |
PublicationTitleAlternate | J Intern Med |
PublicationYear | 2022 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2015; 35 2020; 5 2018; 39 2006; 91 2018; 293 2013; 21 2020; 63 2020; 73 2006; 49 2019; 69 2008; 28 2020; 17 2020; 126 2020; 288 2012; 57 2014; 22 2005; 46 1996; 45 2020; 319 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 |
References_xml | – volume: 22 start-page: 1854 year: 2014 end-page: 9 article-title: Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride‐rich lipoproteins publication-title: Obesity (Silver Spring) – volume: 73 start-page: 202 year: 2020 end-page: 9 article-title: A new definition for metabolic dysfunction‐associated fatty liver disease: an international expert consensus statement publication-title: J Hepatol – volume: 288 start-page: 422 year: 2020 end-page: 38 article-title: Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects publication-title: J Intern Med. – volume: 45 start-page: 817 year: 1996 end-page: 21 article-title: In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated publication-title: Metabolism. – volume: 57 start-page: 1276 year: 2012 end-page: 82 article-title: Patatin‐like phospholipase domain‐containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro publication-title: J Hepatol. – volume: 49 start-page: 755 year: 2006 end-page: 65 article-title: Overproduction of large VLDL particles is driven by increased liver fat content in man publication-title: Diabetologia. – volume: 35 start-page: 2218 year: 2015 end-page: 24 article-title: Kinetic and related determinants of plasma triglyceride concentration in abdominal obesity: multicenter tracer kinetic study publication-title: Arterioscler Thromb Vasc Biol. – volume: 39 start-page: 385 year: 2018 end-page: 93 article-title: Liver fat content, non‐alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta‐analysis of 279 013 individuals publication-title: Eur Heart J. – volume: 91 start-page: 1446 year: 2006 end-page: 52 article-title: Contributions of different fatty acid sources to very low‐density lipoprotein‐triacylglycerol in the fasted and fed states publication-title: J Clin Endocrinol Metab. – volume: 69 start-page: 2427 year: 2019 end-page: 41 article-title: PNPLA3, CGI‐58, and inhibition of hepatic triglyceride hydrolysis in mice publication-title: Hepatology. – volume: 46 start-page: 58 year: 2005 end-page: 67 article-title: A new combined multicompartmental model for apolipoprotein B‐100 and triglyceride metabolism in VLDL subfractions publication-title: J Lipid Res. – volume: 63 start-page: 253 year: 2020 end-page: 60 article-title: Non‐alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality publication-title: Diabetologia. – volume: 21 start-page: 2138 year: 2013 end-page: 45 article-title: A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population publication-title: Obesity (Silver Spring) – volume: 17 start-page: 40 year: 2020 end-page: 52 article-title: Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology publication-title: Nat Rev Gastroenterol Hepatol. – volume: 5 issue: 24 year: 2020 article-title: Effects of TM6SF2 E167K on hepatic lipid and very low‐density lipoprotein metabolism in humans publication-title: JCI Insight – volume: 319 start-page: G469 year: 2020 end-page: G80 article-title: An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase publication-title: Am J Physiol Gastrointest Liver Physiol. – volume: 126 start-page: 679 year: 2020 end-page: 704 article-title: Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases publication-title: Circ Res. – volume: 28 start-page: 1225 year: 2008 end-page: 36 article-title: Overproduction of very low‐density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome publication-title: Arterioscler Thromb Vasc Biol. – volume: 293 start-page: 6958 year: 2018 end-page: 68 article-title: Patatin‐like phospholipase domain‐containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets publication-title: J Biol Chem. – ident: e_1_2_8_2_1 doi: 10.1038/s41575-019-0212-0 – ident: e_1_2_8_19_1 doi: 10.1161/ATVBAHA.107.160192 – ident: e_1_2_8_6_1 doi: 10.1074/jbc.RA118.002333 – ident: e_1_2_8_18_1 doi: 10.1210/jc.2005-1709 – ident: e_1_2_8_3_1 doi: 10.1002/oby.20366 – ident: e_1_2_8_4_1 doi: 10.1016/j.jhep.2020.03.039 – ident: e_1_2_8_9_1 doi: 10.1161/ATVBAHA.115.305614 – ident: e_1_2_8_10_1 doi: 10.1172/jci.insight.144079 – ident: e_1_2_8_5_1 doi: 10.1002/hep.30583 – ident: e_1_2_8_20_1 doi: 10.1152/ajpgi.00049.2020 – ident: e_1_2_8_11_1 doi: 10.1007/s00125-019-05024-3 – ident: e_1_2_8_16_1 doi: 10.1002/oby.20781 – ident: e_1_2_8_8_1 doi: 10.1007/s00125-005-0125-z – ident: e_1_2_8_17_1 doi: 10.1016/j.jhep.2012.07.030 – ident: e_1_2_8_12_1 doi: 10.1093/eurheartj/ehx662 – ident: e_1_2_8_13_1 doi: 10.1111/joim.13017 – ident: e_1_2_8_7_1 doi: 10.1161/CIRCRESAHA.119.316337 – ident: e_1_2_8_15_1 doi: 10.1016/S0026-0495(96)90152-3 – ident: e_1_2_8_14_1 doi: 10.1194/jlr.M400108-JLR200 |
SSID | ssj0013060 |
Score | 2.4249966 |
Snippet | Background
The phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of... The phospholipase domain-containing 3 gene (PNPLA3)-148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride-rich... BackgroundThe phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of... The PNPLA3-148M variant is associated with liver steatosis but its influence on metabolism of triglyceride-rich lipoproteins remains unclear. Here we... |
SourceID | swepub proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 218 |
SubjectTerms | Acyltransferases - genetics Apolipoproteins Cardiology and Cardiovascular Disease Density Fatty liver Homozygotes Humans Kardiologi och kardiovaskulära sjukdomar Kinetics Lipid Metabolism Lipids Lipoproteins Lipoproteins (very low density) Lipoproteins, VLDL - metabolism Liver Liver - metabolism Metabolism Phospholipases A2, Calcium-Independent - genetics Steatosis Triglycerides Triglycerides - metabolism |
Title | Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.13375 https://www.ncbi.nlm.nih.gov/pubmed/34411351 https://www.proquest.com/docview/2620943369 https://www.proquest.com/docview/2563426396 https://gup.ub.gu.se/publication/306550 |
Volume | 291 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fa9RAEB9qC-JL8X9ja1lRBIVIyP7JBXwp2tIWrx5ioW9LNrvbBu6Sw9xR-uZH8DP6SZzZ5GJLRejLkmQnJOzsZH-TnfkNwBuVeGcyIYjoNouFJ5PywsaJt46XmSldKN82PlGHp-L4TJ6twcdVLkzHDzH8cCPLCN9rMvDCtNeNvKlmH9DDyuQ92KDcWqpfkIrJ3z2EJOQII4YQscKFricnDXE8w703l6NbGHMgEL2JXcPic_AQNnvUyPY6NT-CNVc_hvvjfl_8CZiOhLhljWeTk8mXPc6O0AMZs6ZmF46Cpks2reaVZUVtGc7eq98_f02bS2wtRbAvrqi7CaQNVc1mboFzY1q1M4ZnoYxf-xROD_a_fzqM--oJcYmgQMampA12myLAK0YyK6SyAtd_ZySnuC0EIijl8kRK67zxrvBpolIzst5bbtCLeQbrdVO7LWBGWp7Y0oyUQZt3ROiCwDy1We65zXgRwbvVIOqypxanChdTPbgYOOA6DHgErwfZeUeo8U-pnZUudG9UrSbu_FxwrvIIXg3daA60x1HUrlmijFScOOhzFcHzTofDYzhCPypIGMHbTqlDD3Fsny_nGi-dL3XrNM4ddN0ieB-U_p8X1cdfj8bh6MVdhLfhQUp5FCH8ewfWFz-W7iWim4XZDZMY28_f0j_GIvcP |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9QwEB_0BPVF_G_11IgiKFRK86fbx0M8ds_tug93cG-haZKzsNsudhe5Nz-Cn9FP4kzaqx6K4EtpmyktmZnmN8nkNwCvVOKdyYQgotssFp5cygsbJ946XmWmcqF8W7FQ0xNxdCpPh9wc2gvT80OME27kGeF_TQ5OE9K_e3lbr99hiJXJq3BNIDAno07F8tciQhI2CSOIELHCkW5gJw2JPOOzl8ejP0DmyCB6GbyG0efwNtwaYCM76PV8B6645i5cL4aF8XtgehbijrWeLRfL-QFnMwxBCtY27LOjrOmKrepNbVnZWIbme_7j2_dV-xWPllLYt-fU3AbWhrpha7dF41jV3ZrhVajj192Hk8MPx--n8VA-Ia4QFcjYVLTCblNEeOVEZqVUViAAcEZyStxCJIJSLk-ktM4b70qfJio1E-u95QbDmAew17SNewTMSMsTW5mJMuj0jhhdEJmnNss9txkvI3hz0Ym6GrjFqcTFSo8xBna4Dh0ewctRdtMzavxVav9CF3rwqk4TeX4uOFd5BC_GZvQHWuQoG9fuUEYqTiT0uYrgYa_D8TUcsR9VJIzgda_UsYVIts92G423zna6cxptB2O3CN4Gpf_jQ_XRp1kRzh7_j_BzuDE9LuZ6Plt8fAI3U9pUEXLB92Fv-2XnniLU2ZpnwaB_AmHY-Zs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fa9RAEB9qheKL-N_UqiuKoBAJ2T-5gC9FPXq1d96Dhb4t2exuDdwlR3OH9M2P4Gf0kzizyUWLIvhy5LITEnZmsr_JzP4G4IVKvDOZEER0m8XCk0t5YePEW8fLzJQutG-bztTRqTg-k2c78Ha7F6bjhxg-uJFnhPc1OfjK-t-dvKmWbzDCyuQ1uE7ZPiroS8X8Vw4hCXuEEUOIWOFC15OThjqe4dqry9EfGHMgEL2KXcPiM74FN3vUyA47Nd-GHVffgb1pnxe_C6YjIW5Z49l8Nj855GyCEciUNTX74qhoumSLalVZVtSWofVe_vj2fdF8xV9LFezrSxpuAmlDVbOlW6NtLKp2yfBfaOPX3oPT8YfP747ivntCXCIokLEpKcFuUwR4xUhmhVRW4PrvjORUt4VABKVcnkhpnTfeFT5NVGpG1nvLDUYx92G3bmr3EJiRlie2NCNl0OcdEbogME9tlntuM15E8Go7ibrsqcWpw8VCDyEGTrgOEx7B80F21RFq_FXqYKsL3TtVq4k7PxecqzyCZ8MwugPlOIraNRuUkYoTB32uInjQ6XC4DUfoRw0JI3jZKXUYIY7t881K46nzjW6dRtvB0C2C10Hp_3hQffxpMg1H-_8j_BT25u_H-mQy-_gIbqS0pSJUgh_A7vpi4x4j0FmbJ8GefwLbR_jE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+PNPLA3+I148M+on+hepatic+lipid+and+very%E2%80%90low%E2%80%90density+lipoprotein+metabolism+in+humans&rft.jtitle=Journal+of+internal+medicine&rft.au=Bor%C3%A9n%2C+Jan&rft.au=Adiels%2C+Martin&rft.au=Bj%C3%B6rnson%2C+Elias&rft.au=Matikainen%2C+Niina&rft.date=2022-02-01&rft.issn=0954-6820&rft.eissn=1365-2796&rft.volume=291&rft.issue=2&rft.spage=218&rft.epage=223&rft_id=info:doi/10.1111%2Fjoim.13375&rft.externalDBID=10.1111%252Fjoim.13375&rft.externalDocID=JOIM13375 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6820&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6820&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6820&client=summon |